Content provided by alumni UBC and Alumni UBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by alumni UBC and Alumni UBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

People love us!

User reviews

"Love the offline function"
"This is "the" way to handle your podcast subscriptions. It's also a great way to discover new podcasts."

The big nanoparticle story behind the COVID-19 vaccine

37:02
 
Share
 

Manage episode 352740079 series 1950845
Content provided by alumni UBC and Alumni UBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by alumni UBC and Alumni UBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Rumneek and Carol speak with UBC’s Dr. Pieter Cullis (BSc’67, MSc’70, PhD’72), whose pioneering research on lipid nanoparticles (LNPs) has received global acclaim. Without the development of LNPs, which serve as the “delivery system” for life-saving therapeutics, the mRNA COVID vaccines by Pfizer-BioNTech and Moderna would literally not work. Cullis’s success did not happen overnight, but was the result of years of collaborative effort, sprinkled with happy accidents along the way — plus critical early support from UBC.
  continue reading

145 episodes

iconShare
 
Manage episode 352740079 series 1950845
Content provided by alumni UBC and Alumni UBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by alumni UBC and Alumni UBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Rumneek and Carol speak with UBC’s Dr. Pieter Cullis (BSc’67, MSc’70, PhD’72), whose pioneering research on lipid nanoparticles (LNPs) has received global acclaim. Without the development of LNPs, which serve as the “delivery system” for life-saving therapeutics, the mRNA COVID vaccines by Pfizer-BioNTech and Moderna would literally not work. Cullis’s success did not happen overnight, but was the result of years of collaborative effort, sprinkled with happy accidents along the way — plus critical early support from UBC.
  continue reading

145 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Player FM - Podcast App
Go offline with the Player FM app!

Quick Reference Guide